CIK: 1753185 - Address: C/O Y-Mabs Therapeutics, Inc., 230 Park Avenue, Suite 3350, New York, NY 10169
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/12/23 08:26
12/11/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWedell-Wedellsborg JohanNYDP446.850604,559I
12/11/23 17:25
12/7/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWedell-Wedellsborg JohanNYDP.m8906.98012834,553I
12/1/23 17:14
11/29/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWedell-Wedellsborg JohanNYDP3095.9705214,425I
11/29/23 17:15
11/27/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWedell-Wedellsborg JohanNYDP.m5215.5909324,373I
5/17/23 17:07
5/15/23
YMABY-Mabs Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsWedell-Wedellsborg JohanG7DP9819.65010224,280I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact